1. Warning against intrathecal mitoxantrone

   Newsletter Article 05 February 2013 Pages: 2 - 2

2. Sexual dysfunction related to drug use and abuse

   Newsletter Article 05 February 2013 Pages: 2 - 3

3. Heparin and thrombopenia

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. Cocaine: yet another danger associated with abuse

   Newsletter Article 05 February 2013 Pages: 3 - 3

5. Amineptine

   Newsletter Article 05 February 2013 Pages: 4 - 4

6. Amineptine overdose

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Anabolic steroids

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Anabolic steroids see Testosterone/anabolic steroids

   Newsletter Article 05 February 2013 Pages: 4 - 4

9. Antidepressants

   Newsletter Article 05 February 2013 Pages: 5 - 5

10. Antineoplastics

    Newsletter Article 05 February 2013 Pages: 5 - 5

11. Antineoplastics overdose

    Newsletter Article 05 February 2013 Pages: 5 - 5

12. Antipsychotics

    Newsletter Article 05 February 2013 Pages: 5 - 5

13. Apomorphine

    Newsletter Article 05 February 2013 Pages: 5 - 5

14. Atenolol

    Newsletter Article 05 February 2013 Pages: 5 - 5

15. Benzodiazepines overdose

    Newsletter Article 05 February 2013 Pages: 5 - 5

16. Captopril overdose

    Newsletter Article 05 February 2013 Pages: 5 - 6

17. Captopril/enalapril

    Newsletter Article 05 February 2013 Pages: 6 - 6

18. Ciprofloxacin see Rifampicin/ciprofloxacin

    Newsletter Article 05 February 2013 Pages: 6 - 6

19. Clindamycin

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Cocaine abuse

    Newsletter Article 05 February 2013 Pages: 6 - 6

21. Cyclosporin

    Newsletter Article 05 February 2013 Pages: 6 - 6

22. Deferoxamine

    Newsletter Article 05 February 2013 Pages: 6 - 7

23. Diazepam

    Newsletter Article 05 February 2013 Pages: 7 - 7

24. Disopyramide

    Newsletter Article 05 February 2013 Pages: 7 - 7

25. Enalapril

    Newsletter Article 05 February 2013 Pages: 7 - 7

26. Enalapril see Captopril/enalapril

    Newsletter Article 05 February 2013 Pages: 7 - 7

27. Fenoterol

    Newsletter Article 05 February 2013 Pages: 8 - 8

28. Flavone acetic acid

    Newsletter Article 05 February 2013 Pages: 8 - 8

29. Fluorouracil

    Newsletter Article 05 February 2013 Pages: 8 - 8

30. Haloperidol withdrawal

    Newsletter Article 05 February 2013 Pages: 8 - 8

31. Ipratropium bromide

    Newsletter Article 05 February 2013 Pages: 8 - 8

32. Lorazepam withdrawal

    Newsletter Article 05 February 2013 Pages: 8 - 9

33. Methandrostenolone/nandrolone decanoate

    Newsletter Article 05 February 2013 Pages: 9 - 9

34. Methotrexate

    Newsletter Article 05 February 2013 Pages: 9 - 9

35. Naloxone

    Newsletter Article 05 February 2013 Pages: 9 - 9

36. Nandrolone decanoate see Methandrostenolone/nandrolone decanoate

    Newsletter Article 05 February 2013 Pages: 9 - 9

37. Norfloxacin interaction

    Newsletter Article 05 February 2013 Pages: 9 - 9

38. Quinidine

    Newsletter Article 05 February 2013 Pages: 9 - 9

39. Pencillamine

    Newsletter Article 05 February 2013 Pages: 9 - 9

40. Prednisolone

    Newsletter Article 05 February 2013 Pages: 9 - 9

41. Propofol

    Newsletter Article 05 February 2013 Pages: 9 - 10

42. Retinoids

    Newsletter Article 05 February 2013 Pages: 10 - 10

43. Rifampicin/ciprofloxacin

    Newsletter Article 05 February 2013 Pages: 10 - 10

44. Salbutamol

    Newsletter Article 05 February 2013 Pages: 10 - 10

45. Sulfamethoxypyridazine

    Newsletter Article 05 February 2013 Pages: 10 - 10

46. Sulfasalazine

    Newsletter Article 05 February 2013 Pages: 10 - 10

47. Testosterone/anabolic steroids

    Newsletter Article 05 February 2013 Pages: 11 - 11

48. Tranylcypromine overdose

    Newsletter Article 05 February 2013 Pages: 11 - 11

49. Warfarin see Norfloxacin interaction

    Newsletter Article 05 February 2013 Pages: 11 - 11

50. Erratum

    Newsletter Article 05 February 2013 Pages: 11 - 11